RxDoctor Payments Data

Thuy Tran

Physician Assistant · Gulfport, MSNPI 1376092155

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,245 of the $3,617 with a category attached, or 89.7%. It is spread thinly across 18 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations.

$3,617in general payments, 2019–2025

Across 174 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$514
  • Sanofi$514
  • UCB, Inc.$484
  • Johnson & Johnson$459
  • AbbVie$356
  • Galderma Laboratories, L.p.$264
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,24590%
  • Education$37210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,617 in reported general payments places this provider in the 80th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$30,871
Medicare patients
71
Services billed
448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab25$251,015
Dupixent SyringeDupilumab26$104,779
Triamcinolone Acetonide49$543
Ketoconazole35$489
Clobetasol Propionate13$246
Gabapentin13$182

Paid to pharmacies, not to this prescriber.

Other physician assistant in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →